Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 94
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    What can we do to improve survival in babies with respiratory distress in Bangladesh?

    Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

    Bridging International Borders to Fight Re-emerging Plague in Madagascar

    The Plague is considered one of the most successful infectious agents in history and at one point killed nearly...

    Backer Badge Funded